Universal access to HIV treatment in developing countries: going beyond the misinterpretations of the 'cost-effectiveness' algorithm.

AIDS (London, England)

Volumn 22 Suppl 1, Issue , 2008, Pages

  Moatti, Jean Paul ^a   Marlink, Richard ^a   Luchini, Stephane ^a   Kazatchkine, Michel ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; DRUG COST; ECONOMICS; HEALTH CARE ORGANIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; RESOURCE ALLOCATION; REVIEW;

ANTI-HIV AGENTS; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; DRUG COSTS; HEALTH CARE RATIONING; HIV INFECTIONS; HUMANS; RESOURCE ALLOCATION;

EID: 51549086812     PISSN: None     EISSN: 14735571     Source Type: Journal    
DOI: None     Document Type: Review

References (74)